Henan Jindan Lactic Acid Technology (300829)

Search documents
国投创业基金拟减持华曙高科不超2.2%股份;ST路通收到江苏证监局行政监管措施决定书 |公告精选





Mei Ri Jing Ji Xin Wen· 2025-06-08 13:47
Shareholding Changes - Guotou Chuangye Fund plans to reduce its stake in Huashu Gaoke by up to 2.20%, amounting to a maximum of 9.11 million shares [1] - Biheng Investment intends to reduce its stake in Shentong Technology by up to 3%, totaling a maximum of 12.88 million shares [2] - Guangzhou Chengxin plans to reduce its stake in Jindan Technology by up to 2.93%, which is a maximum of 563.5 thousand shares [3] Regulatory Matters - ST Lutong received an administrative regulatory measure decision from Jiangsu Securities Regulatory Bureau due to internal control deficiencies and failure to disclose significant lawsuits and account freezes [4] - Zhongdian Xinlong confirmed that there are no undisclosed significant matters, despite a stock price fluctuation exceeding 20% over two trading days [5] - Yiming Pharmaceutical stated that there have been no significant changes in its internal and external operating environment, and confirmed the absence of undisclosed significant matters [6]
晚间公告丨6月8日这些公告有看头
第一财经· 2025-06-08 11:48
Core Viewpoint - Several listed companies in the Shanghai and Shenzhen markets announced significant updates, including changes in control, regulatory measures, and sales performance, which may present investment opportunities and risks for investors [2]. Company Announcements - Zhongying Electronics announced that its controlling shareholder is planning a change in control, leading to a suspension of trading from June 9, 2025, for up to two trading days [3]. - ST Lutong received an administrative regulatory measure from the Jiangsu Securities Regulatory Bureau due to internal control deficiencies and failure to disclose significant lawsuits and account freezes [4]. - Lianhua Technology clarified that it does not directly produce chlorantraniliprole and that the related matters have limited impact on its overall business [5]. - Longshen Rongfa's subsidiary received a CNAS laboratory accreditation certificate, which is expected to positively influence future operations, though it will not significantly impact current performance [6]. Sales Performance - Yisheng Co. reported a significant increase in May sales of breeding pigs, with a total of 10,849 heads sold, representing a year-on-year increase of 207.08% [7]. Shareholding Changes - Shentong Technology's shareholder, Biheng Investment, plans to reduce its stake by up to 3%, equating to a maximum of 12.88 million shares [8]. - Ruoyuchen's shareholder, Langzi Co., intends to reduce its stake by up to 3%, not exceeding 4.7681 million shares [9]. - Oujing Technology's shareholder, Wanzhao Huigu, plans to reduce its stake by up to 3%, equating to a maximum of 5.7722 million shares [10]. - Jindan Technology's shareholder, Guangzhou Chengxin, plans to reduce its stake by up to 2.93%, equating to a maximum of 5.635 million shares [11]. - Huashu Gaoke's shareholder, Guotou Chuangye Fund, plans to reduce its stake by up to 2.2%, equating to a maximum of 9.1117 million shares [12]. - Zhongke Soft's shareholder, Kesuan Chuangyuan, plans to reduce its stake by up to 2%, equating to a maximum of 16.6208 million shares [13]. - Hengrun Co. announced multiple shareholders planning to reduce their stakes, with total reductions not exceeding 1.89% of the company's shares [14]. - Del Shares' shareholder, Wuxu 15 Fund, plans to reduce its stake by up to 1.987%, equating to a maximum of 3 million shares [15]. - Jian Ke Yuan's shareholder, Jian Ke Investment, plans to reduce its stake by up to 1% [17]. - Mindong Electric's shareholder, Fujian Investment Development Group, plans to reduce its stake by up to 1% [18]. - Puli Software's chairman and executives plan to reduce their stakes by a total of up to 0.69% [19].
晚间公告丨6月8日这些公告有看头
Di Yi Cai Jing· 2025-06-08 10:24
Group 1 - Zhongying Electronics' controlling shareholder is planning a change in control, leading to a stock suspension starting June 9, 2025, for up to 2 trading days [3] - Lianhua Technology clarified that it does not directly produce chlorantraniliprole, and the related matters have limited impact on the company's overall performance [4] - Longshen Rongfa's subsidiary received CNAS laboratory accreditation, which is expected to positively influence future operations, though it will not significantly impact current performance [5] Group 2 - Yisheng Co. reported May sales of breeding pigs at 10,849 heads, a year-on-year increase of 207.08%, with significant sales increases attributed to delayed orders from April [7] - Shentong Technology's shareholder plans to reduce its stake by up to 3%, amounting to no more than 12.88 million shares [9] - Ruoyuchen's major shareholder intends to reduce its stake by up to 3%, not exceeding 476.81 million shares [10] Group 3 - Oujing Technology's major shareholder plans to reduce its stake by up to 3%, not exceeding 577.22 million shares [12] - Jindan Technology's shareholder plans to reduce its stake by up to 2.93%, amounting to no more than 563.5 million shares [13] - Huashu Gaoke's shareholder intends to reduce its stake by up to 2.2%, not exceeding 911.17 million shares [14] Group 4 - Zhongke Soft's major shareholder plans to reduce its stake by up to 2%, not exceeding 16.62 million shares [15] - Hengrun Co.'s shareholders plan to collectively reduce their stake by up to 1.89%, with specific reductions from various shareholders [16] - Del Shares' shareholder plans to reduce its stake by up to 1.987%, not exceeding 3 million shares [17] Group 5 - Jianke Institute's shareholder plans to reduce its stake by up to 1%, not exceeding 146.66 million shares [18] - Mindong Electric's shareholder plans to reduce its stake by up to 1%, not exceeding 457.95 million shares [19] - Puli Software's chairman and executives plan to collectively reduce their stake by up to 0.69% [20]
金丹科技: 河南金丹乳酸科技股份有限公司股东减持股份预披露公告
Zheng Quan Zhi Xing· 2025-06-08 08:07
Core Viewpoint - Guangzhou Chengxin Venture Capital Co., Ltd. plans to reduce its holdings in Henan Jindan Lactate Technology Co., Ltd. by selling up to 614,300 shares, representing 3.19% of the company's total share capital, within a specified period from June 30, 2025, to September 29, 2025 [1][2]. Group 1 - The shareholder, Guangzhou Chengxin, holds 614.33 million shares, which is 3.19% of the total share capital as of the announcement date [1][2]. - The reduction plan includes selling up to 0.98% of the total share capital through centralized bidding and up to 1.95% through block trading within any consecutive 90-day period [2]. - The shareholder has committed to not transferring or entrusting the management of its shares for 12 months post-listing, and this commitment has been strictly adhered to [2].
金丹科技(300829) - 河南金丹乳酸科技股份有限公司股东减持股份预披露公告
2025-06-08 07:45
| 证券代码:300829 | 证券简称:金丹科技 | 公告编号:2025-051 | | --- | --- | --- | | | 债券简称:金丹转债 | | | 债券代码:123204 | | | 河南金丹乳酸科技股份有限公司 股东减持股份预披露公告 股东广州诚信创业投资有限公司保证向公司提供的信息内容真实、准确、 完整,没有虚假记载、误导性陈述或重大遗漏。 (一)股东的名称:广州诚信创业投资有限公司 (二)持股情况:截至本公告披露日,广州诚信持有本公司股份 614.33 万 股,占本公司总股本比例 3.19%(占剔除回购专户股份后总股本比例 3.27%)。 注:本公告中的"占本公司总股本比例"以公司截至 2025 年 6 月 5 日收市后 总股本 192,416,961 股为基数。 二、本次减持计划的主要内容 1 (一)本次减持计划的具体安排 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 特别提示: 持有河南金丹乳酸科技股份有限公司(以下简称本公司、公司或发行人)股 份 614.33 万股,占本公司总股本比例 3.19%(占剔除回购专户股份后总股本比例 3.27%)的股东广州诚 ...
6月6日晚间重要公告一览
Xi Niu Cai Jing· 2025-06-06 10:24
Group 1 - Baiyunshan received drug registration certificate for Tadalafil tablets (2.5mg, 5mg) from the National Medical Products Administration, indicating its entry into the erectile dysfunction treatment market [1] - Huayin Power plans to invest approximately 1.398 billion yuan in three renewable energy projects with a total installed capacity of 230 MW [2] - GAC Group reported a 24.8% year-on-year decline in May automobile sales, with total sales of 117,700 units [3] Group 2 - Honghui Fruits and Vegetables announced a potential change in control due to share transfer negotiations, leading to a temporary suspension of its stock and convertible bonds [4] - Fuyuan Pharmaceutical's subsidiary received a drug registration certificate for Bromhexine Hydrochloride oral solution, aimed at treating respiratory diseases [5][6] - Jianghan New Materials plans to repurchase shares worth 200 million to 400 million yuan, with a maximum price of 30 yuan per share [7][8] Group 3 - Sinan Navigation received an administrative regulatory decision from the Shanghai Securities Regulatory Bureau due to multiple issues in its 2024 annual report [9][10] - Hesheng Co. received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [11] - Daqin Railway reported a 1.85% year-on-year decrease in cargo transportation volume in May, totaling 32.96 million tons [13] Group 4 - Ningbo Construction's subsidiary won a design and construction project with a bid of 787 million yuan [14] - Yuehongyuan A announced the termination of a major asset restructuring plan due to failure to reach an agreement on key terms [15][16] - Mingyang Smart Energy reached a 190 million yuan repurchase agreement with Haiji New Energy [18] Group 5 - CNE Group's subsidiary plans to reduce registered capital from 430 million yuan to 330 million yuan [19] - ST Baili received an administrative penalty for failing to disclose non-operating fund occupation matters, resulting in a fine of 4 million yuan [21] - Baichuan Co. completed the repurchase of a 7.14% stake in its subsidiary for 50 million yuan [22] Group 6 - Dongrui Co. reported May sales of 155,400 pigs, generating revenue of 203 million yuan, a decrease of 8.77% month-on-month [25][26] - Pengding Holdings reported a 22.43% year-on-year increase in May consolidated revenue, totaling 2.598 billion yuan [27] - Dabeinong reported May sales of 727,600 pigs, with total revenue of 1.248 billion yuan [28] Group 7 - Lihua Co. reported a 4.77% year-on-year decrease in May chicken sales revenue, totaling 1.118 billion yuan [29][30] - Jindan Technology plans to use up to 300 million yuan of idle funds for entrusted wealth management [31] - Youxunda won a project from the State Grid worth approximately 176 million yuan [33][34] Group 8 - Shenglan Co. received approval for its convertible bond issuance from the Shenzhen Stock Exchange [35][36] - Jingfang Technology's shareholder plans to reduce holdings by up to 2% of the company's shares [37] - Shiji Information's subsidiary signed a significant contract with Marriott for cloud services [39] Group 9 - Northeast Securities' subsidiary plans to terminate its listing on the New Third Board [40] - Yaji International's supervisor is under investigation for insider trading [42][43] - Yian Technology signed a strategic cooperation framework agreement with Shenzhen Hive Interconnect Technology [44] Group 10 - Jinyu Group's subsidiary acquired a real estate project for 3.364 billion yuan [46][47] - Kaiweite's major shareholder plans to reduce holdings by up to 3% of the company's shares [48] - Ningbo Energy's subsidiary plans to publicly transfer fixed assets valued at approximately 17.4372 million yuan [49]
金丹科技: 关于金丹转债可能满足赎回条件的提示性公告
Zheng Quan Zhi Xing· 2025-06-06 08:15
证券代码:300829 证券简称:金丹科技 公告编号:2025-050 象发行可转换公司债券募集资金验资报告》(大华验字(2023)第 000430 号)。 (二)可转债上市情况 债券代码:123204 债券简称:金丹转债 河南金丹乳酸科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 特别提示: 自 2025 年 5 月 7 日至 2025 年 6 月 6 日,河南金丹乳酸科技股份有限公司 (以下简称公司)股票已有十个交易日的收盘价格不低于"金丹转债"当期转 股价格(自 2025 年 6 月 3 日起转股价格由 14.98 元/股调整为 14.93 元/股)的 若在未来触发"金丹转债"的有条件赎回条款(即:在转股期内,如果公司股 票在任意连续三十个交易日中至少十五个交易日的收盘价格不低于当期转股价 格的 130%(含 130%)),届时根据《河南金丹乳酸科技股份有限公司向不特 定对象发行可转换公司债券募集说明书》(以下简称《募集说明书》)中有条 件赎回条款的相关规定,公司有权决定按照债券面值加当期应计利息的价格赎 回全部或部分未转股的可转换公司 ...
金丹科技(300829) - 关于使用闲置自有资金进行委托理财的公告
2025-06-06 07:58
| 证券代码:300829 | 证券简称:金丹科技 | 公告编号:2025-047 | | --- | --- | --- | | 债券代码:123204 | 债券简称:金丹转债 | | 河南金丹乳酸科技股份有限公司 关于使用闲置自有资金进行委托理财的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示: 1.投资种类:河南金丹乳酸科技股份有限公司(以下简称公司)及合并报 表范围内的子公司拟使用暂时闲置自有资金购买银行、证券公司等金融机构发 行的安全性高、流动性好的各类理财产品。 2.投资金额:公司拟使用总额度不超过人民币3亿元(含本数,下同)的闲 置自有资金进行委托理财,有效期自公司董事会审议通过之日起不超过12个月。 在前述额度和期限范围内,资金可滚动循环使用。 3.特别风险提示:金融市场受宏观经济的影响较大,公司将根据经济形势 及金融市场的变化适时适量的介入,但仍可能出现因受到市场波动影响,导致委 托理财实际收益不及预期的情况。敬请广大投资者注意投资风险。 公司于2025年6月6日召开第五届董事会第二十六次会议、第五届监事会第 二十次会议, ...
金丹科技(300829) - 第五届监事会第二十次会议决议公告
2025-06-06 07:58
本公司及监事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 一、监事会会议召开情况 | | | 河南金丹乳酸科技股份有限公司 第五届监事会第二十次会议决议公告 经与会监事充分讨论,本次会议审议并通过了如下议案: (一)审议通过《关于募投项目延期的议案》。 经审核,监事会认为:公司本次对募集资金投资项目的调整,不存在改变或 变相改变募集资金用途的情形,募投项目的可行性未发生变化,不存在损害股东 利益特别是中小股东利益的情形,也不存在违反中国证监会、深圳证券交易所关 于上市公司募集资金使用的有关规定的情形。 具体内容详见公司同日披露于巨潮资讯网(www.cninfo.com.cn)的《关于募 投项目延期的公告》。 河南金丹乳酸科技股份有限公司(以下简称公司)第五届监事会第二十次会 议于 2025 年 6 月 6 日在公司会议室以现场方式召开。本次监事会会议于 2025 年 6 月 3 日以电话及电子邮件方式通知全体监事。会议应出席监事 3 名,实际出席 监事 3 名,公司董事/副总经理/董事会秘书崔耀军、证券事务代表刘彦宏列席本 次会议。 本次监事会会议由监事会主席史永祯先生 ...
金丹科技(300829) - 国金证券股份有限公司关于河南金丹乳酸科技股份有限公司募集资金投资项目延期、使用闲置募集资金进行现金管理和使用闲置自有资金进行委托理财的核查意见
2025-06-06 07:58
(一)募投项目投资进度情况 国金证券股份有限公司 关于河南金丹乳酸科技股份有限公司 募集资金投资项目延期、使用闲置募集资金进行现金管理 和使用闲置自有资金进行委托理财的核查意见 国金证券股份有限公司(以下简称"保荐机构"、"国金证券")作为河南金 丹乳酸科技股份有限公司(以下简称"金丹科技"、"公司")向不特定对象发行 可转换公司债券并在创业板上市的保荐机构,根据《证券发行上市保荐业务管 理办法》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司 自律监管指引第 2 号——创业板上市公司规范运作》《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》等相关法律、法规和规范性 文件的要求,对金丹科技拟延期募投项目达到预定可使用状态时间、使用闲置 募集资金进行现金管理和使用闲置自有资金进行委托理财的事项进行了审慎核 查,核查情况如下: 一、可转债募集资金的基本情况 经中国证券监督管理委员会《关于同意河南金丹乳酸科技股份有限公司向 不特定对象发行可转换公司债券注册的批复》(证监许可〔2023〕885 号)同 意注册,河南金丹乳酸科技股份有限公司向不特定对象发行 7,000,000 张可转换 ...